top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hPD-L1/hCD39 MC38
Common name
B-hPD-L1/hCD39 MC38 Catalog number    321831
Aliases

B7-H, B7H1, PDCD1L1, PDCD1LG1;

ENTPD1 (SPG64, ATPDase, NTPDase-1)

Disease  Colon carcinoma
Organism
Mouse 
Strain  C57BL/6
Tissue types Colon Tissue  Colon
Description 

The mouse Pdl1 gene and Cd39 gene were replaced by human PD-L1 and CD39 coding sequence in B-hPD-L1/hCD39 MC38 cells. Human PD-L1 and CD39 are highly expressed on the surface of B-hPD-L1/hCD39 MC38 cells.

Application

B-hPD-L1/hCD39 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

Targeting strategy

Gene targeting strategy for B-hPD-L1/hCD39 MC38 cells. The exogenous promoter and human PD-L1 coding sequence was inserted to replace part of murine exon 3. The insertion disrupts the endogenous murine Pdl1 gene, resulting in a non-functional transcript. The exogenous promoter and human CD39 coding sequence were inserted into the targeting vector used in the lentivirus system. 

Protein expression analysis 

from clipboard

PD-L1 and CD39 expression analysis in B-hPD-L1/hCD39 MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hPD-L1/hCD39 MC38 cultures were stained with species-specific anti-PD-L1 and anti-CD39 antibody. Human PD-L1 and CD39 were detected on the surface of B-hPD-L1/hCD39 MC38 cells but not wild-type MC38 cells. The 3-A09 clone of B-hPD-L1/hCD39 MC38 cells was used for in vivo experiments.


Tumor growth curve & Body weight changes


from clipboard

Subcutaneous homograft tumor growth of B-hPD-L1/hCD39 MC38 cells. B-hPD-L1/hCD39 MC38 cells (5x105, 1x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hPD-1/hCD39 mice (female, 8-week-old, n=8). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hPD-L1/hCD39 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

Tumor growth curve of individual mice

from clipboard

B-hPD-L1/hCD39 MC38 tumor cells growth of individual mice. B-hPD-L1/hCD39 MC38 cells(5x105, 1x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hPD-1/hCD39 mice (female, 8-week-old, n=8). As shown in panel, . B-hPD-L1/hCD39 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

Protein expression analysis of tumor cells

from clipboard

B-hPD-L1/hCD39 MC38 cells were subcutaneously transplanted into B-hPD-1/hCD39 mice (n=8), and on 39 days post inoculation, tumor cells were harvested and assessed for human PD-L1 and CD39 expression by flow cytometry. As shown, human PD-L1 and CD39 were highly expressed on the surface of tumor cells. Therefore, B-hPD-L1/hCD39 MC38 cells can be used for in vivo efficacy studies of novel PD-L1 and CD39 therapeutics.